Sponsored by: Hey guys and gals, If you have been watching or trading MYMD the last few weeks, it has been a painful reminder that high-flying stocks can also come back down just as quickly. The good news is that MYMD is trading back at key support levels not...
“How many millionaires do you know who have become wealthy by investing in savings accounts? I rest my case.”
— Robert G. Allen
MYMD
MYMD Provides Dosing Update on Phase 2 Multi-Center Clinical Trial
Latest MYMD Press Release
This Biotech company caught my eye
Sponsored by: If you’ve been following our updates, you know that MYMD-1® seeks to target the CAUSE, not just the symptoms, that drive autoimmunity and inflammation. However, did you also know that MYMD-1® may behave like an ANTIDEPRESSANT? This...
MyMD battling brain-related disorders – let’s gooooo
Sponsored By Recently we’ve been following the story of MyMD, particularly in regard to its lead drug indication – MYMD-1® – in Phase 2 trials for sarcopenia (aka aging). But what led MyMD to pursue this path? As all companies have limited resources,...
Injection, infusion or pill…hmmm🤔
Sponsored By Hello Traders-Jeff Bishop Here! If you’ve been following our updates about MyMD, you know we’ve been focusing primarily on MYMD-1® and its Phase 2 trial as a therapy for delaying aging and prolonging healthy lifespan. To do this, MYMD-1® is...
Scientists Are Obsessed with THESE TWO Questions
Sponsored By Greetings Traders, “What causes a person’s body to attack itself?” and “Why is a particular tissue selected as the target?” Although these questions have completely stumped scientists, what happens to the body has not. Autoimmune diseases wreak...
MYMD raises cash as catalysts approach
Sponsored By See Disclosure Below Hello again, Now that MYMD has improved their cash position through an offering and retraced to $3, let’s take a look why I like it here based on the chart and upcoming catalysts. ...
This stock needs to be on your radar, again
Sponsored By See Disclosure Below Take note, Trader! It has been over a week since I talked about MYMD. As you know, I have been bullish on MyMD for some time now. Why should you care about this tiny biotech stock? For starters, I think that anyone 40 years...
MYMD on FOX
Sponsored by MYMD See Disclosure Below Hello, I hope you have been paying attention to what has been happening with MYMD lately? It is the very first company that we have chosen to work with directly and share with our audience. As you can imagine, I get a...
MyMD Squeeze Play? Check it out!
Sponsored by: Is a squeeze coming on MYMD soon? Let’s dig in. ⛏ In 360 Wall Street, we do a lot of momentum trading. One of the big things we look for is positively stacked EMAs. (Exponential Moving Averages) Momentum tends to play out over a few...
MYMD; the anatomy of trading breakouts
Sponsored By: Good morning trader! ☕ After MYMD had a monster move from under $2 to nearly $5 recently, it touched (almost perfectly) a 38.2% Fibonacci retracement and acted as a springboard for the stock yesterday, which finished up over 10% on the...
Boardroom 7/17- MYMD Fibonacci setup
👋Good morning, It’s very common for stocks to make significant moves higher. And one of the biggest mistakes traders make is getting caught up in the FOMO (fear of missing out) and chasing the move near the top when waiting for a retracement would be a wiser play. So...